Homocysteine and "Buerger's disease"

Postgraduate Medical Journal

Volumn 78, Issue 922, 2002, Pages

  Courtney, P A ^a   Sharpe, Peter C ^a   Lee, R J E ^a  

^a CRAIGAVON AREA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ADULT; ARTERIOGRAPHY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BUERGER DISEASE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HOMOCYSTINURIA; HUMAN; HYPERCOAGULABILITY; NOTE; SMOKING; ARTICLE; DRUG COMBINATION; HYPERHOMOCYSTEINEMIA;

ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; THROMBOANGIITIS OBLITERANS; VITAMIN B 12;

EID: 0036685164     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.922.500     Document Type: Note

References (6)

1. Thromboangiitis obliterans (Buerger's disease)
2. Plasma homocysteine as a risk factor for vascular disease
3. The prevalence of hyperhomocysteinemia in thromboangiitis obliterans
4. Genetic predisposition to hyperhomocysteinaemia: Deficiency of methylenetetrahydrofolate reductase (MTHFR)
5. The effect of a common methylene tetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis
6. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels